TY - JOUR
T1 - Timing of initial antibiotic treatment for febrile neutropenia in the emergency department
T2 - The need for evidence-based guidelines
AU - Kyriacou, Demetrios N.
AU - Jovanovic, Borko
AU - Frankfurt, Olga
PY - 2014/11/1
Y1 - 2014/11/1
N2 - Guidelines for the treatment of febrile neutropenia (FN) universally recommend the prompt initiation (<60 minutes) of antibiotic therapy for patients with this complication presenting to medical settings. Unfortunately, administration delays exist in emergency departments where patients with FN frequently seek care. Future guidelines should be based on investigations that clearly indicate the effectiveness of rapid antibiotic therapy. If definitive investigations identify an optimal time period for the initial administration of antibiotics for patients with FN administrative efforts will be developed to improve the emergency department care of these critically ill patients with cancer.
AB - Guidelines for the treatment of febrile neutropenia (FN) universally recommend the prompt initiation (<60 minutes) of antibiotic therapy for patients with this complication presenting to medical settings. Unfortunately, administration delays exist in emergency departments where patients with FN frequently seek care. Future guidelines should be based on investigations that clearly indicate the effectiveness of rapid antibiotic therapy. If definitive investigations identify an optimal time period for the initial administration of antibiotics for patients with FN administrative efforts will be developed to improve the emergency department care of these critically ill patients with cancer.
UR - http://www.scopus.com/inward/record.url?scp=84908552316&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84908552316&partnerID=8YFLogxK
U2 - 10.6004/jnccn.2014.0157
DO - 10.6004/jnccn.2014.0157
M3 - Article
C2 - 25361804
AN - SCOPUS:84908552316
VL - 12
SP - 1569
EP - 1573
JO - Journal of the National Comprehensive Cancer Network : JNCCN
JF - Journal of the National Comprehensive Cancer Network : JNCCN
SN - 1540-1405
IS - 11
ER -